These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30596092)

  • 1. Corticosteroids for Graves' Ophthalmopathy: Systematic Review and Meta-Analysis.
    Tu X; Dong Y; Zhang H; Su Q
    Biomed Res Int; 2018; 2018():4845894. PubMed ID: 30596092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for Graves' ophthalmopathy: a network meta-analysis.
    Zhou X; Zhou D; Wang J; Chen G
    Br J Ophthalmol; 2020 Apr; 104(4):551-556. PubMed ID: 31272958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined glucocorticoids and cyclophosphamide in the treatment of Graves' ophthalmopathy: a systematic review and meta-analysis.
    Xiang Q; Yang M; Luo W; Cao Y; Shuai S; Wei X; Xiong A
    BMC Endocr Disord; 2024 Jan; 24(1):12. PubMed ID: 38273269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.
    Stiebel-Kalish H; Robenshtok E; Hasanreisoglu M; Ezrachi D; Shimon I; Leibovici L
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2708-16. PubMed ID: 19491222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common Immunosuppressive Monotherapy for Graves' Ophthalmopathy: A Meta-Analysis.
    Mou P; Jiang LH; Zhang Y; Li YZ; Lou H; Zeng CC; Wang QH; Cheng JW; Wei RL
    PLoS One; 2015; 10(10):e0139544. PubMed ID: 26469187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
    Acharya SH; Avenell A; Philip S; Burr J; Bevan JS; Abraham P
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):943-50. PubMed ID: 18429949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tripterygium glycosides for Graves ophthalmopathy: A systematic review and meta-analysis.
    Liu X; Gao C; Liu X; Gao T
    Medicine (Baltimore); 2019 Dec; 98(50):e18242. PubMed ID: 31852090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous glucocorticoids therapy in the treatment of Graves' ophthalmopathy: a systematic review and Meta-analysis.
    Zhao LQ; Yu DY; Cheng JW
    Int J Ophthalmol; 2019; 12(7):1177-1186. PubMed ID: 31341811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic safety analysis of mycophenolate in Graves' orbitopathy.
    Lee ACH; Riedl M; Frommer L; Diana T; Kahaly GJ
    J Endocrinol Invest; 2020 Jun; 43(6):767-777. PubMed ID: 31834613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Rituximab for the Treatment of Graves' Orbitopathy: A Meta-analysis of Randomized Controlled Trials.
    Shen WC; Lee CH; Loh EW; Hsieh AT; Chen L; Tam KW
    Pharmacotherapy; 2018 May; 38(5):503-510. PubMed ID: 29601105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis.
    Li HX; Xiang N; Hu WK; Jiao XL
    J Endocrinol Invest; 2016 Nov; 39(11):1225-1233. PubMed ID: 27220843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves' Ophthalmopathy to Parenteral Corticosteroids.
    Naselli A; Moretti D; Regalbuto C; Arpi ML; Lo Giudice F; Frasca F; Belfiore A; Le Moli R
    Front Endocrinol (Lausanne); 2020; 11():609895. PubMed ID: 33414766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials.
    Viani GA; Boin AC; De Fendi LI; Fonseca EC; Stefano EJ; Paula JS
    Arq Bras Oftalmol; 2012 Oct; 75(5):324-32. PubMed ID: 23471326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
    Kahaly GJ; Riedl M; König J; Pitz S; Ponto K; Diana T; Kampmann E; Kolbe E; Eckstein A; Moeller LC; Führer D; Salvi M; Curro N; Campi I; Covelli D; Leo M; Marinò M; Menconi F; Marcocci C; Bartalena L; Perros P; Wiersinga WM;
    Lancet Diabetes Endocrinol; 2018 Apr; 6(4):287-298. PubMed ID: 29396246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
    Wiersinga WM
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids in the medical treatment of thyroid ophthalmopathy: when and how? Somatostatin analogues: where we stand today.
    Krassas GE; Gogakos A; Boboridis K
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():204-9. PubMed ID: 20467364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of different treatment modalities for active, moderate-to-severe Graves' orbitopathy: a systematic review and network meta-analysis.
    Li H; Yang L; Song Y; Zhao X; Sun C; Zhang L; Zhao H; Pan Y
    Acta Ophthalmol; 2022 Sep; 100(6):e1189-e1198. PubMed ID: 34918472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of moderate to severe orbitopathy: Current modalities and perspectives.
    Bouzehouane N; Borson-Chazot F; Abeillon J; Caron P
    Ann Endocrinol (Paris); 2021 Apr; 82(2):92-98. PubMed ID: 33676921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.